Details of the Drug

General Information of Drug (ID: DM1RAIS)

• Drug Name: NEXI-002

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Phase 1/2	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: D6EI9F

References

• [1] ClinicalTrials.gov (NCT04505813) Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma. U.S. National Institutes of Health.